AMBEVAGEN
Swiss trademark · 697625 · Word mark · In force
Register entry
- Registration number
- 697625
- Application number
- 61892/2016
- Status
- In force
- Type
- Word mark
- Filed
- Sep 27, 2016
- Registered
- Jan 10, 2017
- Published
- Jan 10, 2017
- Protected until
- Sep 27, 2026
- Priority
- 05.04.2016 US
- Language of procedure
- German
- Source
- Swissreg
Goods and services
Pharmaceuticals
Pharmazeutische Präparate; pharmazeutische Präparate zur Behandlung von Krebs; andere pharmazeutische Präparate, nämlich Biosimilars zur Behandlung von Krebs, und pharmazeutische Präparate und Biosimilars zur Behandlung von Störungen und Erkrankungen der Lunge, des Gehirns, sowie ovarialen, renalen und zervikalen Störungen und Erkrankungen.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 14, 2023
Agent’s address changed
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 14.12.2023
- Jan 10, 2017
Registered
Published in Swissreg on 10.01.2017
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.